Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gaucher's disease: current aspects]

M Klein1, P Kaminsky, M Duc

  • 1Service de médecine J, CHU de Nancy, hôpitaux de Brabois, Vandoeuvre-lès-Nancy, France.

La Revue De Medecine Interne
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of kinetics on the determination of the surface reactivity of oxide suspensions by acid-base titration.

Journal of colloid and interface science·2006
Same author

Sorption of selenite ions on hematite.

Journal of colloid and interface science·2006
Same author

Effect of solubility on the determination of the protonable surface site density of oxyhydroxides.

Journal of colloid and interface science·2003
Same author

Serology of typhoid fever in an area of endemicity and its relevance to diagnosis.

Journal of clinical microbiology·2001
Same author

Impaired processing of famous faces in Alzheimer's disease is related to neurofibrillary tangle densities in the prefrontal and anterior cingulate cortex.

Dementia and geriatric cognitive disorders·2000
Same author

Neural substrates of spatial and temporal disorientation in Alzheimer's disease.

Acta neuropathologica·2000
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Gaucher's disease is an inherited disorder caused by glucocerebrosidase deficiency, leading to substrate accumulation and organ damage. Enzyme replacement therapy has significantly improved patient outcomes for this rare genetic condition.

Area of Science:

  • Genetics
  • Biochemistry
  • Pathology

Context:

  • Gaucher's disease is an autosomal recessive inherited disorder.
  • It results from a genetic deficiency of lysosomal glucocerebrosidase.
  • This deficiency causes the substrate glycosylceramide to accumulate in monocyte/macrophage cells.

Purpose:

  • To provide a comprehensive overview of Gaucher's disease.
  • To highlight the genetic basis, clinical manifestations, and diagnostic approaches.
  • To discuss the impact of enzyme replacement therapy.

Summary:

  • Characterized by glucocerebrosidase deficiency, Gaucher's disease leads to glycosylceramide accumulation in macrophages.
  • Clinical features include hepatosplenomegaly, skeletal lesions, and neurological issues in severe cases.

Related Experiment Videos

  • Frequent mutations (N370S, L444P, 84GG, IVS2+1) are noted, especially in the Ashkenazi population.
  • Diagnosis involves identifying Gaucher cells and measuring glucocerebrosidase activity.

    • Impact:

    • Diagnosis of Gaucher's disease relies on identifying Gaucher cells and assessing enzyme activity.
    • Enzyme replacement therapy has substantially improved the prognosis for individuals with Gaucher's disease.
    • Understanding genetic mutations aids in risk assessment and potential targeted therapies.